Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCPS | Q96C86 | 9/20 | 0.60 |
| ▸ | DHFR | P00374 | 10/20 | 0.57 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.49 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.49 |
| ▸ | CAMK2B | Q13554 | 1/20 | 0.49 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.49 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.49 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1154710 | 0.88 | DCPS (0.74) | DCPSDHFRKCNH2 | |
| SCHEMBL1154216 | 0.86 | DCPS (0.75) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5216762 | 0.85 | DCPS (0.68) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5218094 | 0.85 | DHFR (0.78) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5217588 | 0.83 | DCPS (0.58) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5221300 | 0.83 | DCPS (0.60) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5220465 | 0.82 | DCPS (0.56) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5218850 | 0.82 | DCPS (0.61) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5220989 | 0.81 | DCPS (0.68) | DCPSDHFRCSNK1A1CSNK1DPRKCD | |
| SCHEMBL5224697 | 0.81 | DCPS (0.77) | DCPSDHFRCSNK1A1CSNK1DPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1765810-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | Decode Chemistry, Inc. (US) | 2007-03-28 | — | — | EP | claimed |
| WO-2005123724-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | DECODE CHEMISTRY, INC. (US) | 2005-12-29 | — | — | WO | claimed |
| WO-2012167086-A2 | METHODS OF DIAGNOSING AND TREATING AMYOTROPHIC LATERAL SCLEROSIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-12-06 | — | — | WO | disclosed |
| EP-1765810-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | Decode Chemistry, Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2005123724-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | DECODE CHEMISTRY, INC. (US) | 2005-12-29 | — | — | WO | disclosed |